share_log

Insider Purchase: Co-CEO of $LDWY (LDWY) Buys 32,000 Shares

Insider Purchase: Co-CEO of $LDWY (LDWY) Buys 32,000 Shares

內部人士購買:$LDWY(LDWY)的聯席首席執行官購買了32,000股
Quiver Quantitative ·  11/25 10:15

Daniel C. Philp, the Co-CEO of $LDWY ($LDWY), bought 32,000 shares of the company on 11-21-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 118.2%. Following this trade, they now own 59,071 shares of $LDWY stock.

$LDWY Insider Trading Activity

$LDWY insiders have traded $LDWY stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here's a breakdown of recent trading of $LDWY stock by insiders over the last 6 months:

  • DANIEL C. PHILP (Co-CEO) purchased 32,000 shares.
  • MARK JUNDT (Co-CEO) purchased 1,100 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$LDWY Hedge Fund Activity

We have seen 4 institutional investors add shares of $LDWY stock to their portfolio, and 5 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • VANGUARD GROUP INC removed 26,670 shares (-100.0%) from their portfolio in Q3 2024
  • BLACKROCK, INC. removed 11,275 shares (-46.9%) from their portfolio in Q3 2024
  • GEODE CAPITAL MANAGEMENT, LLC added 10,690 shares (+inf%) to their portfolio in Q3 2024
  • SCHONFELD STRATEGIC ADVISORS LLC added 1,700 shares (+5.2%) to their portfolio in Q3 2024
  • UBS GROUP AG added 274 shares (+13700.0%) to their portfolio in Q3 2024
  • TOWER RESEARCH CAPITAL LLC (TRC) removed 217 shares (-14.7%) from their portfolio in Q3 2024
  • ALLWORTH FINANCIAL LP removed 14 shares (-100.0%) from their portfolio in Q2 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論